Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PRA International buys Spanish CRO (clinical research organisation):

This article was originally published in Clinica

Executive Summary

PRA International, the McLean, Virginia-based clinical research organisation (CRO), has acquired Staticon International Espana, a Madrid-based CRO, to expand its international network. Spain and Portugal are important clinical trial locations, David Thomas, vice-president and managing director of PRA's European operations told Clinica. PRA International conducts clinical trials and related services across a network of offices in the US, the UK, France, Germany, Spain and Poland. It also has partnerships in Latin America, South Africa, Australia and Asia. Of the $138 million revenues it expects in 2002, around 40% will be derived from its multi-country clinical trials. PRA also offers a number of complementary activities, including digitisation of medical images and specialised testing.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel